En el ENDOTIPS PCOS revisaremos las guias europeas, la aproximación diagnóstica a los fenotipos y las implicaciones metabolicas y cardiovasculares.
- The polycystic ovary syndrome: a position statement from the European Society of Endocrinology. Conway G, Dewailly D, Diamanti-Kandarakis E, Escobar-Morreale HF, Franks S, Gambineri A, Kelestimur F, Macut D, Micic D, Pasquali R, Pfeifer M, Pignatelli D, Pugeat M, Yildiz BO; ESE PCOS Special Interest Group. Eur J Endocrinol. 2014 Oct;171(4):P1-29 PDF
- Polycystic ovary syndrome–phenotypes and diagnosis. Christakou C, Diamanti-Kandarakis E. Scand J Clin Lab Invest Suppl. 2014;244:18-22 PDF
- Polycystic ovary syndrome: metabolic consequences and long-term management. Carmina E. Scand J Clin Lab Invest Suppl. 2014;244:23-6 PDF
- Oxidative stress and cardiovascular complications in polycystic ovarian syndrome. Hyderali BN Mala K Eur J Obstet Gynecol Reprod Biol. 2015 Aug;191:15-22. PDF
- Polycystic ovary syndrome: cardiovascular risk factors according to specific phenotypes. Aziz M, Sidelmann JJ, Faber J, Wissing ML, Naver KV, Mikkelsen AL, Nilas L, Skouby SO. Acta Obstet Gynecol Scand. 2015 Oct;94(10):1082-9. PDF
